Latest news
Analyst Reiterates Buy on Prothena, Citing Disciplined Capital Strategy and Undervalued TTR Franchise with Unchanged $30 Price Target - TipRanksTipRanks · Fri, 07 Aug 2026 15:11:37 GMTAlnylam Pharmaceuticals (ALNY) On Lowered TTR Guidance And What It Means For Valuation - simplywall.stsimplywall.st · Thu, 06 Aug 2026 14:12:21 GMTAlnylam (ALNY) Turns Profitable as Revenue Mix Shifts: What Changes in Its Investment Story? - simplywall.stsimplywall.st · Tue, 04 Aug 2026 14:29:34 GMTAlnylam (ALNY) Stock Stalls As TTR Sales Top $1b And Guidance Tightens - simplywall.stsimplywall.st · Fri, 31 Jul 2026 22:37:58 GMTAlnylam Pharmaceuticals (ALNY) Could Be 34% Undervalued After Alzheimer’s Pipeline Update - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMT